RT Journal Article
SR Electronic
T1 AI-Driven CT-based quantification, staging and short-term outcome prediction of COVID-19 pneumonia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.17.20069187
DO 10.1101/2020.04.17.20069187
A1 Chassagnon, Guillaume
A1 Vakalopoulou, Maria
A1 Battistella, Enzo
A1 Christodoulidis, Stergios
A1 Hoang-Thi, Trieu-Nghi
A1 Dangeard, Severine
A1 Deutsch, Eric
A1 Andre, Fabrice
A1 Guillo, Enora
A1 Halm, Nara
A1 Hajj, Stefany El
A1 Bompard, Florian
A1 Neveu, Sophie
A1 Hani, Chahinez
A1 Saab, Ines
A1 Campredon, Aliénor
A1 Koulakian, Hasmik
A1 Bennani, Souhail
A1 Freche, Gael
A1 Lombard, Aurelien
A1 Fournier, Laure
A1 Monnier, Hippolyte
A1 Grand, Téodor
A1 Gregory, Jules
A1 Khalil, Antoine
A1 Mahdjoub, Elyas
A1 Brillet, Pierre-Yves
A1 Ba, Stéphane Tran
A1 Bousson, Valérie
A1 Revel, Marie-Pierre
A1 Paragios, Nikos
YR 2020
UL http://medrxiv.org/content/early/2020/04/22/2020.04.17.20069187.abstract
AB Chest computed tomography (CT) is widely used for the management of Coronavirus disease 2019 (COVID-19) 49 pneumonia because of its availability and rapidity1–3. The standard of reference for confirming COVID-19 relies on microbiological tests but these tests might not be available in an emergency setting and their results are not immediately available, contrary to CT. In addition to its role for early diagnosis, CT has a prognostic role by allowing visually evaluating the extent of COVID-19 lung abnormalities4, 5. The objective of this study is to address prediction of short-term outcomes, especially need for mechanical ventilation. In this multi-centric study, we propose an end-to-end artificial intelligence solution for automatic quantification and prognosis assessment by combining automatic CT delineation of lung disease meeting expert’s performance and data-driven identification of biomarkers for its prognosis. AI-driven combination of variables with CT-based biomarkers offers perspectives for optimal patient management given the shortage of intensive care beds and ventilators6, 7.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A